Food and Drug Administration (FDA) officially approved the GLP-1 medication Ozempic to help reduce the risk of worsening kidney disease in adults with type 2 diabetes and chronic kidney disease
But the new UPenn research suggests that the full picture may be more complex, particularly around hormonal and temperature-related symptoms
Furthermore, most professional medical insurance providers in the UK wont cover practitioners using unlicensed products, leaving patients vulnerable if a complication occurs
It may be especially appealing for patients who prefer not to use injections or who have limited insurance coverage
Book your appointment at LIVE Hydration Spa today and start your journey to glowing skin and improved wellness!
Hence, by targeting the enzymatic activity of SARM1, inhibitors may effectively prevent the depletion of NAD + , thereby maintaining cellular energy homeostasis and enhancing neuronal resilience, potentially expanding the treatment landscape for various neurological conditions